United States v. Turk

139 F.R.D. 615, 1991 WL 280260
CourtDistrict Court, D. Maryland
DecidedOctober 29, 1991
DocketCiv. No. HM-89-3161
StatusPublished
Cited by18 cases

This text of 139 F.R.D. 615 (United States v. Turk) is published on Counsel Stack Legal Research, covering District Court, D. Maryland primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States v. Turk, 139 F.R.D. 615, 1991 WL 280260 (D. Md. 1991).

Opinion

MEMORANDUM AND ORDER

HERBERT F. MURRAY, Senior District Judge.

The plaintiff in this civil action is the United States of America. The United States has brought suit against Ellis Turk, M.D. (“Dr. Turk”) seeking civil penalties for violation of the record keeping requirements of the Controlled Substances Act, 21 U.S.C. §§ 827(a)(3) and 842(a)(5). Dr. Turk is registered with the United States Drug Enforcement Agency (“DEA”) and is certified to dispense certain controlled substances to his patients. During December, 1988, an unannounced “compliance inspection” by the DEA reportedly revealed that Dr. Turk had failed to maintain accurate records of controlled substances received and sold by him. The government alleges that Dr. Turk could not account for 1460 30 mg. capsules of Phentermine and that he further could not account for 10,638 35 mg. tablets of Phendimetrazine, both scheduled controlled substances. The government seeks fines of $25,000 for each of the two violations pursuant to section 842(c)(1).

21 U.S.C. § 827(a)(3) provides in relevant part:

[Ejvery registrant under this subchap-ter manufacturing, distributing, or dispensing a controlled substance or substances shall maintain, on a current basis, a complete and accurate record of each such substance manufactured, received, sold, delivered, or otherwise disposed of by him____

21 U.S.C. § 842(a)(5) prohibits the refusal or failure “to make, keep, or furnish any record, report, notification, declaration, order or order form, statement, invoice, or information required” under the applicable provisions.

During December of 1988, two agents for the DEA conducted separate audits of Dr. Turk’s records concerning his receipt, sale, and delivery of these controlled substances. As part of their investigation, the agents physically counted the dosage units on hand at the defendant’s practice as of December 12, 1988. The agents then examined Dr. Turk’s ledger book to determine the number of tablets on hand as of December 29, 1987, the beginning of the audit period, and examined his monthly dispensing records. As part of their investigation, the agents contacted Dr. Turk’s supplier, Moore Medical Corporation, to confirm the number of dosage units he had acquired. During this period, defendant reported no losses or thefts to the DEA. In the course of these investigations, Special Agent David Bruce determined that Dr. Turk could not account for 1919 capsules of Phentermine or 10,631 tablets of Phendimetrazine. Prior to the institution of this lawsuit, DEA Diversion Investigator Roderick Watson reviewed Agent Bruce’s calculations and determined that Dr. Turk could not account for 1469 capsules of Phentermine or 10,638 tablets of Phendime-trazine. As a result of their findings, the government initiated the instant litigation.

Presently pending before the Court are what appear to be cross-motions for summary judgment filed by the opposing parties. Dr. Turk, who has no legal training and is proceeding pro se, has vigorously, if not entirely professionally, denied these claims against him. Legally, the issue before the Court is quite simple: There is no dispute that Dr. Turk was licensed by the DEA to dispense controlled substances and as such was legally obligated to conform to the record keeping requirements of 21 U.S.C. §§ 827(a)(3) and 842(a)(5). The only issue in dispute is whether the defendant in fact complied with those requirements.

Summary judgement pursuant to Federal Rule of Civil Procedure 56 is only appropriate if there is no “genuine issue of material fact.” Anderson v. Liberty Lobby, Inc., 477 U.S. 242, 248, 106 S.Ct. 2505, 2510, 91 [617]*617L. Ed.2d 202 (1986) (emphasis in original). There is no question that the issue of whether Dr. Turk complied with the Controlled Substances Act is material to the present litigation. “[Disputes over facts that might affect the outcome of the suit under the governing law will properly preclude the entry of summary judgment.” Id.; see also 10A C. Wright, A. Miller, & M. Kane, Federal Practice and Procedure § 2725, pp. 93-95 (1983). The controlling issue before this Court is whether the factual dispute over Dr. Turk’s inventory is genuine. A factual dispute can only be considered genuine if “the evidence is such that a reasonable jury could return a verdict for [Dr. Turk].” Anderson, 477 U.S. at 248, 106 S.Ct. at 2510. “If the evidence is merely colorable, or is not significantly probative, summary judgment may be granted.” Id. at 249-50, 106 S.Ct. at 2511 (citing Dumbrowski v. Eastland, 387 U.S. 82, 87 S.Ct. 1425,18 L.Ed.2d 577 (1967) and First National Bank of Arizona v. Cities Service Co., 391 U.S. 253, 88 S.Ct. 1575, 20 L.Ed.2d 569 (1968)).

As stated previously, Dr. Turk, who is representing himself in this matter, vigorously denies the claims against him as well as the factual conclusions of the government auditors. In his opposition to the government’s motion, Dr. Turk argues that Agent Bruce’s figures “may be off the mark by a multiple factor of 5 or 6 times too much____ In order for me to have dispensed the number of pills Mr. Bruce claims, I would have to have seen more than 200 patients per day, rather than the 35 to 40 patients which was about our average per day.” Memorandum of Points and Authorities in Support of Defendant’s Opposition to Plaintiff’s Motion for Summary Judgment at 9-10. It therefore appears to the Court that there is a genuine issue of materia] fact in this case; namely whether Dr. Turk dispensed or otherwise disposed of controlled drugs without complying with the record keeping requirements of the Controlled Substances Act.

A complicating factor in this case is the fact that on December 11, 1989, the government requested Admissions of Fact that apparently were never responded to by Dr. Turk. The requested admissions, if admitted, would certainly have been dispositive of the factual issues presented to the Court. Specifically, the government requested admissions from the defendant concerning the number of dosage units on hand at the beginning of the audit period, the number purchased during this period, the number on hand at the end of the period, and the number dispensed and otherwise disposed of during the audit period. Plaintiff’s Motion for Summary Judgment at 6. Dr. Turk has never responded to these requests despite being ordered to do so by the Memorandum and Order of Magistrate Judge Blake dated November 1, 1990. Id.

Federal Rule of Civil Procedure

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Little v. Young
D. South Carolina, 2025
Grinnell v. Russell
D. South Carolina, 2024
King v. Harmon
W.D. Kentucky, 2022
O'Brien v. Walmart, Inc.
D. Maryland, 2022
Yates v. Overholt
E.D. North Carolina, 2021
United States v. Ayyad
D. Maryland, 2019
United States ex rel. Graybar Electric Co. v. Team Construction, LLC
275 F. Supp. 3d 737 (E.D. North Carolina, 2017)
Warren v. Cybulski
556 B.R. 429 (N.D. California, 2016)
Burger v. Hartley
896 F. Supp. 2d 1157 (S.D. Florida, 2012)
United States v. Renfrow
612 F. Supp. 2d 677 (E.D. North Carolina, 2009)
Citibank (S.D.), N.A. v. Savage (In Re Savage)
303 B.R. 766 (D. Maryland, 2003)
Kress v. Food Employers Labor Relations Ass'n
285 F. Supp. 2d 678 (D. Maryland, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
139 F.R.D. 615, 1991 WL 280260, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-v-turk-mdd-1991.